Rhumbline Advisers »

Protalix Biotherapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $96k 77k 1.26
2023-12-31 $131k 74k 1.78
2023-09-30 $158k 95k 1.66
2023-06-30 $177k 89k 2.00